SCM
TVGNW icon

Shaolin Capital Management’s Tevogen Bio Warrant TVGNW Stock Holding History

Shaolin Capital Management’s Portfolio TVGNW Stock Details TVGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-249,957
Closed -$10K – 628
2023
Q2 		$10K Buy
+249,957
New +$13.5K ﹤0.01% 549

Other funds holding TVGNW

Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Shaolin Capital Management's TVGNW Position: Q3 2024 in Review

Shaolin Capital Management sold out of Tevogen Bio Warrant (TVGNW) in Q3 2024, closing a stake of 282,130 shares — an estimated $8.32K sold.

Shaolin Capital Management first reported a position in TVGNW in Q2 2022 and held it in 8 quarters. The position peaked at $40K in Q2 2022. 37 funds tracked by Wall St. Rank hold TVGNW as of Q3 2024.

  • Shaolin Capital Management reported no remaining Tevogen Bio Warrant position as of Q3 2024 after selling out during the quarter.
  • Shaolin Capital Management sold 282,130 Tevogen Bio Warrant shares in Q3 2024, an estimated $8.32K.
  • Shaolin Capital Management first reported a position in Tevogen Bio Warrant in Q2 2022 and held it in 8 quarters.
  • Shaolin Capital Management's Tevogen Bio Warrant position peaked at $40K in Q2 2022.
  • 37 funds tracked by Wall St. Rank held Tevogen Bio Warrant as of Q3 2024.

Based on Shaolin Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.